Browsing Centre for Immunobiology by Author "Tabak, F"
Now showing items 1-2 of 2
-
Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
Strasser, S; Chan, H; Ahn, S; Chuang, W; Hui, A; Tabak, F; Mehta, R; Petersen, J; Lee, C; Ma, X (2015-09) -
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
Marcellin, P; Ahn, SH; Chuang, W-L; Hui, AJ; Tabak, F; Mehta, R; Petersen, J; Lee, C-M; Ma, X; Caruntu, FA (2016-11)